This suggests that in contrast to TGFBI (transforming growth factor, beta induced) with its hot spots for corneal dystrophy-associated amino acid substitution, CHST6 does not demonstrate a highly conserved number of disease-causing mutations [23]. This evidence concerns the gene CHST6 and corneal dystrophy.